Cargando…

Histone Deacetylase Inhibition Restores Expression of Hypoxia-Inducible Protein NDRG1 in Pancreatic Cancer

OBJECTIVES: N-myc downstream-regulated gene-1 (NDRG1) is a hypoxia-inducible and differentiation-related protein and candidate biomarker in pancreatic cancer. As NDRG1 expression is lost in high-grade tumors, the effects of the differentiating histone deacetylase inhibitor trichostatin A (TSA) were...

Descripción completa

Detalles Bibliográficos
Autor principal:	Tiffon, Céline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5777573/ https://www.ncbi.nlm.nih.gov/pubmed/29303911 http://dx.doi.org/10.1097/MPA.0000000000000982

Ejemplares similares

Cellular differentiation determines the expression of the hypoxia-inducible protein NDRG1 in pancreatic cancer
por: Angst, E, et al.
Publicado: (2006)

Targeting pancreatic cancer immune evasion by inhibiting histone deacetylases
por: Sim, Wynne, et al.
Publicado: (2022)

The Histone Deacetylase Inhibitor, Vorinostat, Represses Hypoxia Inducible Factor 1 Alpha Expression through Translational Inhibition
por: Hutt, Darren M., et al.
Publicado: (2014)

Histone Deacetylase Inhibition Restores Retinal Pigment Epithelium Function in Hyperglycemia
por: Desjardins, Danielle, et al.
Publicado: (2016)

Histone Deacetylase 6 Inhibition Restores Leptin Sensitivity and Reduces Obesity
por: Çakır, Işın, et al.
Publicado: (2022)

Histone Deacetylase Inhibitors Restore Cancer Cell Sensitivity towards T Lymphocytes Mediated Cytotoxicity in Pancreatic Cancer
por: Looi, Chin-King, et al.
Publicado: (2022)

Inhibition of Histone Deacetylases Attenuates Morphine Tolerance and Restores MOR Expression in the DRG of BCP Rats
por: He, Xiao-Tao, et al.
Publicado: (2018)

Inhibiting histone deacetylases suppresses glucose metabolism and hepatocellular carcinoma growth by restoring FBP1 expression
por: Yang, Jing, et al.
Publicado: (2017)

Hypoxia-independent gene expression signature associated with radiosensitisation of prostate cancer cell lines by histone deacetylase inhibition
por: Jonsson, Marte, et al.
Publicado: (2016)

Histone Deacetylase Inhibitors: The Epigenetic Therapeutics That Repress Hypoxia-Inducible Factors
por: Chen, Shuyang, et al.
Publicado: (2011)

NDRG3-mediated lactate signaling in hypoxia
por: Park, Kyung Chan, et al.
Publicado: (2015)

Histone deacetylase inhibition is synthetically lethal with arginine deprivation in pancreatic cancers with low argininosuccinate synthetase 1 expression
por: Kim, Stephanie S., et al.
Publicado: (2020)

Defining Parallels between the Salivary Glands and Pancreas to Better Understand Pancreatic Carcinogenesis
por: Tiffon, Céline
Publicado: (2020)

Targeting histone deacetylases in pancreatic ductal adenocarcinoma
por: Schneider, Günter, et al.
Publicado: (2010)

Hypoxia upregulates the expression of the NDRG1 gene leading to its overexpression in various human cancers
por: Cangul, Hakan
Publicado: (2004)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

Histone deacetylase 9 regulates breast cancer cell proliferation and the response to histone deacetylase inhibitors
por: Lapierre, Marion, et al.
Publicado: (2016)

Histone deacetylases, microRNA and leptin crosstalk in pancreatic cancer
por: Tchio Mantho, Cynthia I, et al.
Publicado: (2017)

Role of histone deacetylase 1 in distant metastasis of pancreatic ductal cancer
por: Shinke, Go, et al.
Publicado: (2018)

Sulforaphane attenuates cisplatin-induced hearing loss by inhibiting histone deacetylase expression
por: Wang, Jie, et al.
Publicado: (2021)

Histone Deacetylases and Their Inhibition in Candida Species
por: Garnaud, Cécile, et al.
Publicado: (2016)

The hypoxia-responsive lncRNA NDRG-OT1 promotes NDRG1 degradation via ubiquitin-mediated proteolysis in breast cancer cells
por: Lin, Hsin-Chen, et al.
Publicado: (2017)

Irisin Ameliorates Hypoxia/Reoxygenation-Induced Injury through Modulation of Histone Deacetylase 4
por: Zhao, Yu Tina, et al.
Publicado: (2016)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
por: Sanaei, Masumeh, et al.
Publicado: (2019)

Theophylline Restores Histone Deacetylase Activity and Steroid Responses in COPD Macrophages
por: Cosio, Borja G., et al.
Publicado: (2004)

Inhibition of BET Proteins and Histone Deacetylase (HDACs): Crossing Roads in Cancer Therapy
por: Manzotti, Gloria, et al.
Publicado: (2019)

Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
por: Freese, Kim, et al.
Publicado: (2019)

NDRG1 is expressed in human granulosa cells: An implicative role of NDRG1 in the ovary
por: Nishigaki, Akemi, et al.
Publicado: (2022)

Impaired histone deacetylases 5 and 6 expression mimics the effects of obesity and hypoxia on adipocyte function
por: Bricambert, Julien, et al.
Publicado: (2016)

Possible Role of Autophagy in the Treatment of Pancreatic Cancer with Histone Deacetylase Inhibitors
por: Rikiishi, Hidemi
Publicado: (2010)

Histone deacetylase 6 in cancer
por: Li, Ting, et al.
Publicado: (2018)

Expression Profile of Histone Deacetylase 1 in Gastric Cancer Tissues
por: Choi, Jae‐Hoon, et al.
Publicado: (2001)

Effects of Histone Deacetylase Inhibitor (Valproic Acid) on the Expression of Hypoxia-inducible Factor-1 Alpha in Human Retinal Müller Cells
por: Kim, Young Jun, et al.
Publicado: (2017)

Histone deacetylase inhibition: a novel approach to cancer treatment
por: Cheson, B D
Publicado: (2006)

Inhibition of histone deacetylases in cancer therapy: lessons from leukaemia
por: Ceccacci, Elena, et al.
Publicado: (2016)

NDRG1 promotes endothelial dysfunction and hypoxia-induced pulmonary hypertension by targeting TAF15
por: Li, Chengwei, et al.
Publicado: (2023)

Defect of Adaptation to Hypoxia in Patients With COPD Due to Reduction of Histone Deacetylase 7
por: To, Masako, et al.
Publicado: (2012)

NDRG3 lowers the metastatic potential in prostate cancer as a feedback controller of hypoxia-inducible factors
por: Lee, Ga Young, et al.
Publicado: (2018)

Beyond Histone and Deacetylase: An Overview of Cytoplasmic Histone Deacetylases and Their Nonhistone Substrates
por: Yao, Ya-Li, et al.
Publicado: (2011)

The histone deacetylase inhibitor M344 as a multifaceted therapy for pancreatic cancer
por: Knoche, Shelby M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uphg09nk9v65nld9llhf9nas6d